Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Last Close
Jan 13  •  04:00PM ET
1.81
Dollar change
+0.20
Percentage change
12.42
%
Index- P/E- EPS (ttm)-0.64 Insider Own12.03% Shs Outstand126.09M Perf Week17.53%
Market Cap228.42M Forward P/E- EPS next Y- Insider Trans0.07% Shs Float106.98M Perf Month19.08%
Enterprise Value263.33M PEG- EPS next Q- Inst Own45.53% Short Float12.20% Perf Quarter-25.51%
Income33.12M P/S9.18 EPS this Y- Inst Trans73.55% Short Ratio3.00 Perf Half Y-74.76%
Sales24.89M P/B0.15 EPS next Y- ROA4.01% Short Interest13.05M Perf YTD64.55%
Book/sh12.18 P/C31.20 EPS next 5Y- ROE4.35% 52W High10.95 -83.47% Perf Year-71.36%
Cash/sh0.06 P/FCF- EPS past 3/5Y55.49% 39.27% ROIC2.12% 52W Low1.08 68.37% Perf 3Y22.38%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-32.09% -18.61% Gross Margin27.42% Volatility11.24% 10.82% Perf 5Y-59.51%
Dividend TTM- EV/Sales10.58 EPS Y/Y TTM92.06% Oper. Margin-90.09% ATR (14)0.17 Perf 10Y-71.04%
Dividend Ex-DateApr 01, 2022 Quick Ratio0.79 Sales Y/Y TTM250.06% Profit Margin133.06% RSI (14)62.80 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.79 EPS Q/Q552.18% SMA2033.36% Beta1.86 Target Price18.00
Payout- Debt/Eq0.01 Sales Q/Q53.31% SMA5010.41% Rel Volume1.34 Prev Close1.61
Employees10 LT Debt/Eq0.01 EarningsAug 25 SMA200-62.39% Avg Volume4.35M Price1.81
IPONov 07, 1991 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume5,913,441 Change12.42%
Jan-12-26 08:23AM
Jan-08-26 08:00AM
Jan-05-26 08:00AM
Dec-30-25 08:30AM
Dec-29-25 12:53PM
09:48AM Loading…
09:48AM
07:53AM
Dec-22-25 03:00AM
Dec-18-25 08:00AM
Dec-11-25 08:08AM
Dec-10-25 05:01PM
Dec-09-25 07:30AM
Dec-06-25 09:00AM
Dec-04-25 05:20PM
Dec-03-25 09:35AM
03:32AM Loading…
03:32AM
Dec-02-25 04:01PM
03:22PM
Nov-28-25 06:43AM
Nov-27-25 03:08PM
10:51AM
02:33AM
Nov-25-25 10:06AM
Nov-14-25 01:17PM
Nov-05-25 10:09AM
Oct-23-25 11:05AM
Oct-22-25 07:14AM
Oct-14-25 08:00AM
Oct-08-25 04:05PM
Oct-07-25 07:31PM
09:00AM Loading…
Oct-06-25 09:00AM
Oct-02-25 03:52AM
Sep-27-25 07:30AM
Sep-25-25 01:59PM
Sep-10-25 09:39AM
05:02AM
Sep-09-25 03:23PM
02:31PM
09:08AM
Sep-07-25 10:00AM
Sep-05-25 12:27PM
12:08PM
Sep-04-25 01:55PM
11:30AM
Sep-03-25 12:34PM
Sep-02-25 10:30AM
Aug-31-25 09:01AM
05:00AM
Aug-26-25 12:21PM
12:04PM
Aug-25-25 10:30AM
Aug-24-25 08:00PM
Aug-20-25 08:00AM
Aug-18-25 10:30AM
Aug-14-25 05:00PM
Aug-13-25 04:24PM
10:30AM
08:49AM
Aug-12-25 07:39PM
10:55AM
09:51AM
06:19AM
Aug-11-25 06:39PM
01:59PM
10:30AM
10:22AM
09:06AM
07:00AM
Jul-30-25 10:00AM
Jul-18-25 04:00PM
Jul-01-25 04:05PM
Jun-30-25 08:00AM
Jun-11-25 12:00PM
May-27-25 09:00AM
08:30AM
May-21-25 04:18PM
May-14-25 09:18AM
May-13-25 08:00AM
May-09-25 05:00PM
Apr-10-25 08:00AM
Mar-31-25 10:30AM
Mar-28-25 04:10PM
Mar-26-25 09:00AM
Feb-26-25 02:00PM
Feb-20-25 08:30AM
Feb-18-25 08:30AM
Feb-13-25 03:00PM
Feb-03-25 07:30AM
Jan-31-25 03:51PM
Jan-15-25 07:00AM
Jan-10-25 08:30AM
Jan-09-25 11:30AM
Dec-18-24 04:00PM
Nov-27-24 07:00AM
Nov-12-24 05:23PM
Nov-06-24 08:30AM
Oct-30-24 10:30AM
Oct-23-24 05:00PM
Oct-09-24 08:30AM
Oct-02-24 08:30AM
ALT5 Sigma Corp. is a multidisciplinary organization with a focus on healthcare and fintech. The firm provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. It operates through the following segments: Biotechnology and Corporate and Other. The Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Corporate and Other segment consists of certain corporate general and administrative costs. Its platforms: ALT5 Pay and ALT5 Prime. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANZIGER DAVID C.DirectorAug 14 '25Buy7.3010,00073,00020,000Oct 09 12:28 PM